Publications:142
- Home
- Profiles
Emilia M Sordillo, MD, PhD
Internal Medicine
No Patient Experience Ratings
- About Me
- Education & Certifications
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Education
MD, Weill Medical College of Cornell University
Internship, Internal Medicine
Henry Ford Hospital
Residency, Internal Medicine
Henry Ford Hospital
Fellowship, Infectious Disease
St. Luke's-Roosevelt Hospital Center
Certifications
American Board of Internal Medicine
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- SARS-CoV-2 serosurvey across multiple waves of the COVID-19 pandemic in New York City between 2020–2023. Juan Manuel Carreño, Abram L. Wagner, Brian Monahan, Gagandeep Singh, Daniel Floda, Ana S. Gonzalez-Reiche, Johnstone Tcheou, Ariel Raskin, Dominika Bielak, Sara Morris, Miriam Fried, Temima Yellin, Leeba Sullivan, Emilia Mia Sordillo, Aubree Gordon, Harm van Bakel, Viviana Simon, Florian Krammer, Fatima Amanat, Guha Asthagiri Arunkumar, Christina Capuano, Jordan Ehrenhaus, Shelcie Fabre, Matthew M. Hernandez, Kaijun Jiang, Brian Lerman, Meagan McMahon, Daniel Stadlbauer, Jessica Tan, Catherine Teo, Kathryn Twyman. Nature Communications
- Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants. Romel Rosales, Briana L. McGovern, M. Luis Rodriguez, Rocio Leiva-Rebollo, Randy Diaz-Tapia, Jared Benjamin, Devendra K. Rai, Rhonda D. Cardin, Annaliesa S. Anderson, Hala Alshammary, R. Banu, K. Farrugia, Ana Silvia Gonzalez-Reiche, A. Paniz-Mondolfi, J. Polanco, Emilia Mia Sordillo, Harm van Bakel, Viviana Simon, Adolfo García-Sastre, Kris M. White. Antiviral Research
- SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase. Komal Srivastava, Juan Manuel Carreño, Charles Gleason, Brian Monahan, Gagandeep Singh, Anass Abbad, Johnstone Tcheou, Ariel Raskin, Giulio Kleiner, Harm van Bakel, Emilia Mia Sordillo, Hala Alshammary, Angela A. Amoako, Dalles Andre, Mahmoud Awawda, Maria C. Bermúdez-González, Katherine F. Beach, Dominika Bielak, Gianna Y. Cai, Rachel L. Chernet, Christian Cognigni, Yuexing Chen, Lily Q. Eaker, Emily D. Ferreri, Daniel L. Floda, Miriam Fried, Joshua Z. Hamburger, Denise Jurczyszak, Hyun Min Kang, Neko Lyttle, Julia C. Matthews, Jacob Mauldin, Wanni A. Mendez, Jacob Mischka, Sara Morris, Lubbertus C.F. Mulder, Ismail Nabeel, Jessica R. Nardulli, Jose Polanco, Annika Oostenink, Aria Rooker, Kayla T. Russo, Ashley Beathrese Salimbangon, Miti S. Saksena, Amber A. Shin, Levy A. Sominsky, Daniel Stadlbauer, Ania Wajnberg, Florian Krammer, Viviana Simon. Immunity
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sordillo has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Sordillo has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.